ITIH4 and neoplasm: S100A9 supports proliferation and metastasis in other tumor types; S100A9, hemopexin, and inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) were identified in saliva of patients with RCC and were suggested as potential biomarkers for disease screening [57].